Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
5.79
-0.20 (-3.34%)
At close: Apr 1, 2025, 4:00 PM
5.97
+0.18 (3.19%)
After-hours: Apr 1, 2025, 6:00 PM EDT

Cogent Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-255.86-192.41-140.24-72.27-74.81
Upgrade
Depreciation & Amortization
4.353.595.881.990.72
Upgrade
Loss (Gain) From Sale of Assets
-0.01---7.49
Upgrade
Asset Writedown & Restructuring Costs
---0.4-44.81
Upgrade
Loss (Gain) From Sale of Investments
-7.62-5.17-1.64--
Upgrade
Stock-Based Compensation
39.7430.6218.3711.696.02
Upgrade
Other Operating Activities
--1.7-1.36-0.340.22
Upgrade
Change in Accounts Receivable
----2
Upgrade
Change in Accounts Payable
1.364.812.362.75-2.45
Upgrade
Change in Unearned Revenue
-----1.32
Upgrade
Change in Other Net Operating Assets
10.246.63-1.61-2.58-3.55
Upgrade
Operating Cash Flow
-207.79-153.62-118.64-58.76-35.85
Upgrade
Capital Expenditures
-0.57-2.8-6.86-1.72-
Upgrade
Sale of Property, Plant & Equipment
----0.32
Upgrade
Investment in Securities
38.85-95.03-117.86--
Upgrade
Other Investing Activities
----8.1
Upgrade
Investing Cash Flow
38.28-97.82-124.72-1.728.42
Upgrade
Issuance of Common Stock
226.15174.24174.3639.26140.56
Upgrade
Other Financing Activities
-11.7-10.7-10.8-1.29-12.76
Upgrade
Financing Cash Flow
214.45163.54163.5637.98232.2
Upgrade
Net Cash Flow
44.94-87.91-79.8-22.51204.77
Upgrade
Free Cash Flow
-208.36-156.42-125.5-60.48-35.85
Upgrade
Free Cash Flow Margin
-----455.47%
Upgrade
Free Cash Flow Per Share
-2.00-1.96-2.13-1.56-3.23
Upgrade
Levered Free Cash Flow
-115.91-86.68-67.08-31.78-15.46
Upgrade
Unlevered Free Cash Flow
-115.91-86.68-67.08-31.78-15.46
Upgrade
Change in Net Working Capital
-13.03-11.99-7.93-3.480.14
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q